0000939767-19-000048.txt : 20190222
0000939767-19-000048.hdr.sgml : 20190222
20190222193545
ACCESSION NUMBER: 0000939767-19-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190221
FILED AS OF DATE: 20190222
DATE AS OF CHANGE: 20190222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAPADOPOULOS STELIOS
CENTRAL INDEX KEY: 0001202098
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 19627796
MAIL ADDRESS:
STREET 1: 3 SOMERSET DRIVE SOUTH
CITY: GREAT NECK
STATE: NY
ZIP: 11020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1228
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_155088213177229.xml
FORM 4
X0306
4
2019-02-21
0
0000939767
EXELIXIS, INC.
EXEL
0001202098
PAPADOPOULOS STELIOS
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
1
0
0
0
Common Stock
2019-02-21
4
M
0
11250
4.16
A
1053501
D
Common Stock
2019-02-21
4
M
0
15000
4.57
A
1068501
D
Common Stock
2019-02-21
4
S
0
26250
21.25
D
1042251
D
Option (right to buy)
4.16
2019-02-21
4
M
0
11250
0
D
2009-05-14
2019-05-13
Common Stock
11250.0
0
D
Option (right to buy)
4.57
2019-02-21
4
M
0
15000
0
D
2012-05-24
2019-05-23
Common Stock
15000.0
0
D
Includes 7,937 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.24 to $21.28. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009.
The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2019-02-22